ARCHIVES

Chemo Combinations Tested In Phase III For Lung Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 8 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year

January 11, 1991

New Tool Found To Cut DNA At Any Position

April 4, 1986

NCI Contracts: Advisors OK Renewal Of chemoprevention Contracts By DCPC

September 6, 1996

Irinotecan And Carboplatin Improve Response In NSCLC

June 24, 2005

NCI Study Finds No Greater Cancer Risk Near Nuclear Plants

September 28, 1990

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995